SBIO

Dapper_Addition_3837

Solid aggressive tilt, but it’s too concentrated and has overlap/risk issues for a 7-12y horizon.Quick revised version (still very aggressive but cleaner): * VWCE/VWRL → 30% (keep broad world exposure, lower than before) * Nasdaq-100 (e.g. QDVE or UPRO if levered ok) → 35% (your main growth engine) * Emerging Markets (e.g. EIMI or EMIM) → 15% (good, bump a bit) * ASML → 5-7% (10% single stock is too much for 7y goal) * Biotech/AI biotech (SBIO or similar) → 8-10% * Bitcoin/ETH (spot ETF if available) → 5% max (volatility killer if it dumps 70%+ again) Total equity \~95-98%, BTC 5%. Expected return high, but drawdowns can easily hit -50% or worse.Key fixes: * Cut ASML to ≤7% (one Dutch fab delay = -30% fast) * Don’t double-count Nasdaq exposure (VWRL already has \~20-25% US tech) * Cap BTC at 5% – it’s a lottery ticket, not the core If your broker really sucks for ETFs, just go 50% Nasdaq-100 + 30% EM + 10% SBIO + 5-7% ASML + 5% BTC and call it a day. Still >90% equity, very aggressive, simpler. You’re fine with -60% drawdowns for a few years, right? If not, dial Nasdaq to 25-30%.

Orange_Codex

There are still crazy things happening. For instance, the SBIO token functions as the 'stock' of Vector Space Industries: a start-up experimenting with manufacturing drugs in orbital microgravity. Holders of the token get access to Vector's early data.

beemerteam

Thanks for your interest! To clarify, *SBIO* is not a traditional stock ticker but rather a utility token that powers access to CubeSatGPT™ services and other offerings within the Vector Space Biosciences ecosystem. It's part of our blockchain-enabled model for stakeholders, collaborators, and customers. As for a target price, the value of SBIO tokens is determined by market dynamics and adoption within our ecosystem, including demand for our services and partnerships. We focus on building real-world utility and value through applications in biotechnology, pharmaceuticals, materials science, and beyond.

Suspicious_Art_5158

I'd put the 1k in SBIO - no doubt. Hold it to 2040 and retire. It's a startup company with a equity-arm and a crypto-arm, the future way to structure a company. This WILL be the the new to model companys and VSB is one of the first. Operating in CubeSats and AI modeling. You can look up - Vector Space Biosciences. I say this because my point is that you should put your 1k where the future is headed (as for me - I know - humans are never going to Mars unless we solve the Space Biosciences protecting us from space stressors), like Space, asteroid mining (sounds like fiction? My guess is we're about 10 years away from being able to do this), deep space travel with cubesats and AI models to convert experiment results. Buy the future man! And create generational wealth. 1K is a good start! Good luck!🚀

Suspicious_Art_5158

Yes. SBIO is the equity token, while VXV is the utility token for the company.

Holiday-Cartoonist

Isn’t VXV VectorSpace AI? Vector Space Biosciences is SBIO.

Suspicious_Art_5158

Vector Space Biosciences - wait until the space race kicks in!! It's going to be epic. $SBIO

VXVWhale

Vector Space Biosciences (SBIO) not to be mistaken with SBIO ETF. they are in process with registering their on chain equity (SBIO) and are offering it via secondary offering. I took part in their friends and family funding round.

beemerteam

Here's another good biomedical play, SBIO - [interviewed on the NASDAQ floor recently](https://www.youtube.com/watch?v=yvO-bkyoSoA)

beemerteam

I'd take a look at Vector Space Biosciences (SBIO) https://www.globenewswire.com/news-release/2023/10/10/2757697/0/en/New-to-The-Street-Signs-Vector-Space-Biosciences-Inc-to-6-Part-Media-Series.html

flowerpenguin167

I like ETFs a lot! I do still invest in individual socks with my standard trade account, but I also have a Roth IRA where invest almost exclusively in ETFs. I'm personally a fan of picking in ETFs based on industries I believe in and/or want to support; some of my favorites include ICLN for clean energy, HERO for gaming, YOLO for cannabis (which I originally invested in years ago when it was under $10, that's definitely worked out well for me!), and SBIO for medical breakthroughs. I also bought into JETS for the pandemic dip, because I figure air travel is likely to pick back up eventually. I'll be the first to admit, no DD or deep logic here, I tend to just pick an industry I like, then skim analyst reports for relevant ETFs to narrow which one(s) I'm going to buy into. It's worked out pretty well for me so far!